Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Elzovantinib |
| Trade Name | |
| Synonyms | TPX0022|TPX 0022|TPX-0022 |
| Drug Descriptions |
Elzovantinib inhibits Met, Csf1r, and Src, which may lead to growth inhibition in tumor cells (PMID: 38564707, NCI Drug Dictionary). |
| DrugClasses | CSF1R Inhibitor 28 MET Inhibitor 59 SRC Inhibitor 31 |
| CAS Registry Number | 2271119-26-5 |
| NCIT ID | C162676 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Elzovantinib | Elzovantinib | 0 | 1 |
| Elzovantinib + Osimertinib | Elzovantinib Osimertinib | 0 | 0 |